Clin2
NCT06631287Possibly a fitRecruiting

Testing baricitinib for persistent long COVID symptoms

Long COVIDSars-CoV-2 InfectionCoronavirus InfectionsCOVID-19

Treatments studied

Part of Infections, Lungs & breathing clinical trials.

This trial tests whether the anti-inflammatory drug baricitinib can improve persistent long COVID symptoms like brain fog, fatigue, and shortness of breath. You may qualify if you had COVID-19 at least 6 months ago and still have bothersome symptoms that affect your daily life.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 3
Enrollment
550 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You had a positive COVID-19 test at least 6 months ago.
  • You have at least one ongoing long COVID symptom, like brain fog, fatigue, or shortness of breath, that started or got worse after your infection.
  • Your symptoms have lasted for at least 6 months and affect your daily life.
  • You have some cognitive trouble (like memory or concentration issues), confirmed by a short questionnaire.
  • You are willing to take a pill (baricitinib or placebo) and attend study visits.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06974084Not yet recruiting· Phase 2/Phase 3
Studying two drugs for long covid symptoms

This trial tests whether a combination of two existing drugs, maraviroc and atorvastatin, can help reduce long covid symptoms like fatigue, brain fog, and shortness of breath. It aims to improve daily functioning for people who have had symptoms for more than six months.

Tucson, Arizona
NCT06928272Recruiting· Phase 3
Long COVID drug study for adults 18 to 65

This study tests whether a commonly used drug (repurposed) can help improve Long COVID symptoms like fatigue, breathing problems, or brain fog. It is for adults 18 to 65 who had COVID-19 in the past 4 years and still have symptoms after 3 months.

San Diego, California
NCT06452095Recruiting
Hyperbaric oxygen therapy for long COVID brain fog

This trial tests if hyperbaric oxygen therapy (breathing pure oxygen in a pressurized chamber) helps with long COVID symptoms, especially brain fog and thinking problems. It may be an option if you have had lingering symptoms for at least 2 months and can travel to one of the study sites.

Toronto, Ontario
NCT07108036Recruiting· Phase 2
Testing Anktiva for Long COVID Symptoms

This trial tests a medicine called Anktiva to see if it can help people with Long COVID. It's for adults who had a confirmed COVID-19 infection and now have lasting symptoms like fatigue, brain fog, or trouble breathing.

San Francisco, California
NCT06045338Recruiting
Mind-body program for long COVID symptoms

This trial tests a mind-body intervention to help people with ongoing long COVID symptoms like pain, fatigue, or brain fog. If you've had COVID-19 and have had symptoms at least 3 days a week for 3 months, this study might help.

Boston, Massachusetts
NCT06883513Recruiting
Osteopathic therapy for long COVID symptoms

This trial tests if gentle hands-on treatment (osteopathic manipulative therapy) can help relieve long-lasting COVID symptoms like fatigue, brain fog, and body pain.

Louisville, Kentucky

Hear when a new Long COVID trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.